| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 0.1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |